盐酸考尼伐坦合成工艺改进

仇传菊

PDF(3754 KB)
主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA
PDF(3754 KB)
中国医药工业杂志 ›› 2016, Vol. 47 ›› Issue (10) : 1223. DOI: 10.16522/j.cnki.cjph.2016.10.003
化学药物与合成技术 Chemical Drug & Synthetic Technology

盐酸考尼伐坦合成工艺改进

作者信息 +

Improved Synthetic Process of Conivaptan Hydrochloride

Author information +
History +

摘要

2-[(4- 甲基苯磺酰基) 胺基] 苯甲酸甲酯(6) 与4- 氯丁腈在相转移催化剂聚乙二醇-400 和混合碱(KOH+K2CO3)作用下发生N- 烷基化反应得2-[N-(3- 氰基丙基) -4- 甲基苯磺酰胺基] 苯甲酸甲酯,经缩合关环、脱氰基、溴代、与盐酸乙脒缩合关环、脱磺酰基得2- 甲基-1,4,5,6- 四氢咪唑并[4,5-d][1] 苯并氮?(5)。另用2- 苯基苯甲酸与4- 氨基苯甲酸在N,N'- 羰基二咪唑(CDI) 作用下发生酰胺化反应得4-(2- 苯基苯甲酰胺基) 苯甲酸,与5 在CDI 作用下经酰胺化、成盐反应得盐酸考尼伐坦,总收率37.6% ( 以6 计)。

Abstract

Methyl 2-[(4-methylphenyl)sulfonamido]benzoate(6) reacted with 4-chlorobutyronitrile via N-alkylation in the presence of the phase transfer catalyst PEG-400 and mixed bases(KOH+K2CO3) to afford methyl 2-[[N-(3-cyanopropyl)-4-methylphenyl]sulfonamido]benzoate, after condensation, cyclization, decyanation,
bromination, ring-closing with acetamidine hydrochloride and then removing the sulfonyl-group, 2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepine(5) was obtained. Meanwhile, [1,1'-biphenyl]-2-carboxylic acid reacted with 4-aminobenzoic acid via acid-amine condensation under the action of N,N'-carbonyldiimidazole(CDI) to give 4-[(1,1'-biphenyl)-2-yl-carboxamido]benzoic acid, after reacting with 5 via acid-amine condensation reaction and
salification with hydrochloric acid, conivaptan hydrochloride was obtained with an overall yield of 37.6%(based on 6).

关键词

盐酸考尼伐坦 / 中间体 / 低钠血症 / 合成工艺

Key words

conivaptan hydrochloride / intermediate / hyponatremia / synthetic process

引用本文

导出引用
仇传菊. 盐酸考尼伐坦合成工艺改进. 中国医药工业杂志. 2016, 47(10): 1223 https://doi.org/10.16522/j.cnki.cjph.2016.10.003
QIU Chuanju. Improved Synthetic Process of Conivaptan Hydrochloride. Chinese Journal of Pharmaceuticals. 2016, 47(10): 1223 https://doi.org/10.16522/j.cnki.cjph.2016.10.003

参考文献

[1] Mayinger B, Hensen J. Nonpeptide vasopressin antagonists: a new group of hormone blockers entering the scene [J]. Exp Clin Endocrinol Diabetes, 1999, 107(3):157—165.

[2] 陆志成. 盐酸考尼伐坦:非肽类双重抑制剂[N] . 医药经济报, 2006, 第A06 版, 药物评价.

[3] 马亚娟, 李晓东, 李 蕴, 等. 盐酸考尼伐坦关键中间体N-甲苯磺酰基苯并氮杂?-5- 酮合成工艺的改进[J]. 应用化学, 2014, 31(1): 50—53.

[4] Tsunoda T, Tanaka A, Mase T, et al. A new synthetic route to YM087, an arginine vasopressin antagonist [J]. Heterocycles, 2004, 35(36): 1113—1122.

[5] Tsunoda T, Yamazaki A, Mase T, et al. A scalable process for the synthesis of 2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d] [ 1] benzazepine monohydrate and 4-[ ( biphenyl-2-ylcarbonyl)amino]benzoic acid: two new key intermediates for the synthesis of the AVP antagonist conivaptan hydrochloride [J]. Org Proc Res Dev, 2005, 9(5): 593—598.

[6] 郑登宇, 高文磊, 赵 俊, 等. 盐酸考尼伐坦的合成[J]. 中国医药工业杂志, 2015, 46(9): 939—942.
PDF(3754 KB)

181

Accesses

0

Citation

Detail

段落导航
相关文章

/